Announcements

Job Offers

Top 5 -yesterday

Top 5 -last week

Top 5 -last month

IL: Acquisition completed of Hefer Valley-based farm operations

Isracann Biosciences has acquired a 50% interest in a joint venture called Cannation for a phased partnership of two near-term farm operations located in the Hefer Valley region of Israel.

"Cannation has an offtake agreement with Focus Medical Herbs, a licensed medical cannabis producer in Israel, for a three-year definitive supply agreement with Cannation for approximately 2,600kg of medical cannabis per year, for a total of up to 7,800kg of medical cannabis over three years," the team with the company explains. "Focus Medical has an exclusive commercial agreement with IM Cannabis to distribute its production under the IMC brand."

"Isracann’s joint venture partner in Cannation is Way of Life Medical Cannabis Company. Way of Life is a regionally respected and active cannabis grower. The principals of Way of Life enjoy a family history of building and operating greenhouse operations across the middle east and proven sector ability with over 2-years experience as owners of a stable and productive cannabis farm servicing the domestic Israeli market. Their technical proficiency includes an active tissue culture program and most importantly, has resulted in securing critical plant genetics which will be available to the JV operation."

"The Cannation farm properties are Israel Medical Cannabis (IMC) compliant and designed to EU-GMP certification standards," they further explain. "Cannation anticipates permits to begin selling its first crop by the end of Q2. Full scale production targets a combined total projected yield of 12,600kg of dried cannabis flow per year with facilities housing over 160,000 sq. ft. of greenhouse canopy. The Cannation farms are located on a 2,000,000 sq. ft. parcel of private land, which provides the potential for expanded production and processing operations. Private lands are rarely available in Israel and are free from the requirement of land commission regulatory approval, thereby minimizing licensing delays."

Company CEO, Darryl Jones notes, “Now that we have concluded the transaction, we are very pleased to be able to provide further insights into this exciting venture. Not only have we achieved a partnership agreement with a farm operation that is constructed, it also has already closed a major offtake agreement for the next three years.  As we noted previously this accelerates our timeline to production and revenue. We look forward to a rapidly advancing and mutually beneficial partnership with the team at Way of Life and for the continued success of the Cannation venture.”.

For more information:
Isracann Biosciences
Tel: +1 855.205.0226
inquiries@isracann.com 
isracann.com  


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber